Treatment with Vacc-HIV (Vacc-C5/Vacc-4x) in patients with HIV infections.
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2013
At a glance
- Drugs Vacc HIV (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 24 Jun 2013 Bionor Pharma has received partial funding from the Research Council of Norway for this trial, according to a media release.
- 13 Jul 2012 New trial record